Abstract
INTRODUCTION: This study presents a novel multi-view learning approach for machine learning (ML)–based Alzheimer's disease (AD) diagnosis. METHODS: A diffusion model is proposed to synthesize the fluorodeoxyglucose positron emission tomography (FDG PET) view from the magnetic resonance imaging T1 weighted imaging (MRI T1WI) view and incorporate two synthesis strategies: one-way synthesis and two-way synthesis. To assess the utility of the synthesized views, we use multilayer perceptron (MLP)–based classifiers with various combinations of the views. RESULTS: The two-way synthesis achieves state-of-the-art performance with a structural similarity index measure (SSIM) at 0.9380 and a peak-signal-to-noise ratio (PSNR) at 26.47. The one-way synthesis achieves an SSIM at 0.9282 and a PSNR at 23.83. Both synthesized FDG PET views have shown their effectiveness in improving diagnostic accuracy. DISCUSSION: This work supports the notion that ML-based cross-domain data synthesis can be a useful approach to improve AD diagnosis by providing additional synthesized disease-related views for multi-view learning. Highlights: We propose a diffusion model with two strategies to synthesize fluorodeoxyglucose positron emission tomography (FDG PET) from magnetic resonance imaging T1 weighted imaging (MRI T1WI). We raise multi-view learning with MRl T1Wl and synthesized FDG PET for Alzheimer's disease (AD) diagnosis. We provide a comprehensive experimental comparison for the synthesized FDG PET view. The feasibility of synthesized FDG PET view in AD diagnosis is validated with various experiments. We demonstrate the ability of synthesized FDG PET to enhance the performance of machine learning–based AD diagnosis.
Original language | English |
---|---|
Journal | Alzheimer's and Dementia |
DOIs | |
Publication status | Published - 6 Dec 2024 |
Keywords
- Alzheimer's disease
- data synthesis
- diffusion model
- fluorodeoxyglucose positron emission tomography
- magnetic resonance imaging T1 weighted imaging
- multi-view learning
ASJC Scopus subject areas
- Epidemiology
- Health Policy
- Developmental Neuroscience
- Clinical Neurology
- Geriatrics and Gerontology
- Cellular and Molecular Neuroscience
- Psychiatry and Mental health